Bionomics Limited(BNOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BNOX Bionomics Limited

Market Closed 10-04 16:00:00 EDT

0.2859

+0.0079

+2.84%

盘后0.2900

+0.0041+1.43%

17:48 EDT

High0.3400	Low0.2780	Vol439.18K
Open0.2780	D1 Closing0.2780	Amplitude22.30%
Mkt Cap4.95M	Tradable Cap3.47M	Total Shares17.32M
T/O135.20K	T/O Rate3.62%	Tradable Shares12.15M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BNOX","market":"US","secType":"STK","nameCN":"Bionomics Limited","latestPrice":0.2859,"timestamp":1728072000000,"preClose":0.278,"halted":0,"volume":439183,"hourTrading":{"tag":"盘后","latestPrice":0.29,"preClose":0.2859,"latestTime":"17:48 EDT","volume":7324,"amount":2045.8911,"timestamp":1728078487671},"delay":0,"floatShares":12148711,"shares":17320349,"eps":-1.551279,"marketStatus":"Market Closed","change":0.0079,"latestTime":"10-04 16:00:00 EDT","open":0.278,"high":0.34,"low":0.278,"amount":135198.12985464002,"amplitude":0.223022,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.551279,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1728288000000},"marketStatusCode":7,"adr":0,"adrRate":180,"listingDate":1639630800000,"exchange":"NASDAQ","adjPreClose":0.278,"preHourTrading":{"tag":"盘前","latestPrice":0.278,"preClose":0.278,"latestTime":"09:26 EDT","volume":2126,"amount":617.859183,"timestamp":1728048395475},"postHourTrading":{"tag":"盘后","latestPrice":0.29,"preClose":0.2859,"latestTime":"17:48 EDT","volume":7324,"amount":2045.8911,"timestamp":1728078487671},"volumeRatio":0.6550085934356987},"requestUrl":"/m/hq/s/BNOX/wiki","defaultTab":"wiki","newsList":[{"id":"2472340708","title":"Bionomics Limited announces intention to re-domicile to the United States","url":"https://stock-news.laohu8.com/highlight/detail?id=2472340708","media":"GlobeNewswire","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472340708?lang=en_us&edition=fundamental","pubTime":"2024-10-01 18:30","pubTimestamp":1727778600,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia and CAMBRIDGE, Mass., Oct.  01, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (“Bionomics” or the “Company”), a clinical-stage biotechnology company developing novel, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/01/2955907/0/en/Bionomics-Limited-announces-intention-to-re-domicile-to-the-United-States.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNQmain","BK4139","SQQQ","NQmain","TQQQ","BK4211","QLD",".IXIC","QID","UBCP","PSQ","BNOX"],"gpt_icon":1},{"id":"2464876587","title":"Bionomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2464876587","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464876587?lang=en_us&edition=fundamental","pubTime":"2024-09-03 18:30","pubTimestamp":1725359400,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia,and CAMBRIDGE, Mass., Sept.  03, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/03/2939462/0/en/Bionomics-to-Present-at-the-H-C-Wainwright-26th-Annual-Global-Investment-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNS","BNOX","BK4135"],"gpt_icon":0},{"id":"2456109646","title":"Bionomics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2456109646","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2456109646?lang=en_us&edition=fundamental","pubTime":"2024-08-01 18:15","pubTimestamp":1722507300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BNOX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  August 01, 2024 06:15 ET (10:15 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNOX"],"gpt_icon":0},{"id":"2455188792","title":"Bionomics Announces Successful End-of-Phase 2 Meeting with the FDA on the Development of BNC210 in Post-Traumatic Stress Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2455188792","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455188792?lang=en_us&edition=fundamental","pubTime":"2024-07-31 18:30","pubTimestamp":1722421800,"startTime":"0","endTime":"0","summary":"Successful End-of-Phase 2 (EoP2) meeting with U.S. Food and Drug Administration (FDA) provides a potential path to New Drug Application (NDA) submission for BNC210 for post-traumatic stress disorder (","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/07/31/2921691/0/en/Bionomics-Announces-Successful-End-of-Phase-2-Meeting-with-the-FDA-on-the-Development-of-BNC210-in-Post-Traumatic-Stress-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4212","LFT","BK4110","CNS","BK4139","POST","BNOX","BK4135"],"gpt_icon":0},{"id":"2455615740","title":"Bionomics to Provide a Corporate Update and Discuss End-of-Phase 2 Meeting Outcomes on the Development of BNC210 in PTSD on July 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2455615740","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2455615740?lang=en_us&edition=fundamental","pubTime":"2024-07-30 04:30","pubTimestamp":1722285000,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia and CAMBRIDGE, Mass., July  29, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/07/29/2920628/0/en/Bionomics-to-Provide-a-Corporate-Update-and-Discuss-End-of-Phase-2-Meeting-Outcomes-on-the-Development-of-BNC210-in-PTSD-on-July-31-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4135","BK4139","CNS","BNOX"],"gpt_icon":0},{"id":"2452347994","title":"Bionomics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2452347994","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452347994?lang=en_us&edition=fundamental","pubTime":"2024-07-19 00:54","pubTimestamp":1721321640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BNOX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 18, 2024 12:54 ET (16:54 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNOX"],"gpt_icon":0},{"id":"2452106498","title":"Bionomics Initiates AFFIRM-1, a Phase 3 Clinical Trial with BNC210 for Social Anxiety Disorder","url":"https://stock-news.laohu8.com/highlight/detail?id=2452106498","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2452106498?lang=en_us&edition=fundamental","pubTime":"2024-07-18 18:30","pubTimestamp":1721298600,"startTime":"0","endTime":"0","summary":"Topline results are expected in Q3 2025 ADELAIDE, Australiaand CAMBRIDGE, Mass., July  18, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a biotechnology company de","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/07/18/2915128/0/en/Bionomics-Initiates-AFFIRM-1-a-Phase-3-Clinical-Trial-with-BNC210-for-Social-Anxiety-Disorder.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4135","BNOX","CNS"],"gpt_icon":0},{"id":"2443604255","title":"Bionomics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2443604255","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2443604255?lang=en_us&edition=fundamental","pubTime":"2024-06-13 01:38","pubTimestamp":1718213880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BNOX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 12, 2024 13:38 ET (17:38 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNOX"],"gpt_icon":0},{"id":"2440844665","title":"Bionomics Secures Growth Through Strategic Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2440844665","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2440844665?lang=en_us&edition=fundamental","pubTime":"2024-06-04 05:57","pubTimestamp":1717451848,"startTime":"0","endTime":"0","summary":"Bionomics (BNOX) has released an update. Bionomics Limited, an Australian biotech firm, has entered into a Securities Purchase Agreement with selec...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bionomics-secures-growth-through-strategic-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bionomics-secures-growth-through-strategic-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BNOX","BK4139"],"gpt_icon":0},{"id":"2439399870","title":"Bionomics Limited Announces Private Placement of up to $70.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2439399870","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2439399870?lang=en_us&edition=fundamental","pubTime":"2024-05-31 20:00","pubTimestamp":1717156800,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australia and CAMBRIDGE, Mass., May  31, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (“Bionomics” or the “Company”), a clinical-stage biotechnology company developing novel, p","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/31/2891488/0/en/Bionomics-Limited-Announces-Private-Placement-of-up-to-70-0-Million.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNOX","BK4139"],"gpt_icon":0},{"id":"2436489175","title":"Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2436489175","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2436489175?lang=en_us&edition=fundamental","pubTime":"2024-05-20 10:30","pubTimestamp":1716172200,"startTime":"0","endTime":"0","summary":"ADELAIDE, Australiaand CAMBRIDGE, Mass., May  20, 2024  (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/05/20/2884721/0/en/Bionomics-to-Present-at-the-2024-American-Society-of-Clinical-Psychopharmacology-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BNOX","CNS","AFG","BK4107","BK4135","BK4117"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bionomics.com.au","stockEarnings":[{"period":"1week","weight":-0.5531},{"period":"1month","weight":-0.5532},{"period":"3month","weight":-0.5807},{"period":"6month","weight":-0.7169},{"period":"1year","weight":-0.9246},{"period":"ytd","weight":-0.8068}],"compareEarnings":[{"period":"1week","weight":0.0026},{"period":"1month","weight":0.04},{"period":"3month","weight":0.0331},{"period":"6month","weight":0.1052},{"period":"1year","weight":0.3498},{"period":"ytd","weight":0.2055}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. The company has a collaboration with Merck & Co., Inc. to identify novel a7 Nicotinic Acetylcholine Receptor PAMs suitable for the treatment of cognitive disorder. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.","exchange":"NASDAQ","name":"Bionomics Limited","nameEN":"Bionomics Limited"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Bionomics Limited(BNOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Bionomics Limited(BNOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Bionomics Limited,BNOX,Bionomics Limited股票,Bionomics Limited股票老虎,Bionomics Limited股票老虎国际,Bionomics Limited行情,Bionomics Limited股票行情,Bionomics Limited股价,Bionomics Limited股市,Bionomics Limited股票价格,Bionomics Limited股票交易,Bionomics Limited股票购买,Bionomics Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Bionomics Limited(BNOX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Bionomics Limited(BNOX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction